Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats
- 14 November 2007
- journal article
- toxicokinetics and-metabolism
- Published by Springer Nature in Archives of Toxicology
- Vol. 82 (3) , 151-157
Abstract
The tissue distribution and toxicity of intravenously administered nanoparticles of titanium dioxide (TiO2) (>10 wt.% at 2 in serum (5 mg/kg body weight), and the tissue content of TiO2 was determined 1, 14, and 28 days later. Biochemical parameters and antigens in serum were also assessed to determine potential pathological changes. The health and behavior of the animals were normal throughout the study. There were no detectable levels of TiO2 in blood cells, plasma, brain, or lymph nodes. The TiO2 levels were highest in the liver, followed in decreasing order by the levels in the spleen, lung, and kidney, and highest on day 1 in all organs. TiO2 levels were retained in the liver for 28 days, there was a slight decrease in TiO2 levels from day 1 to days 14 and 28 in the spleen, and a return to control levels by day 14 in the lung and kidney. There were no changes in the cytokines and enzymes measured in blood samples, indicating that there was no detectable inflammatory response or organ toxicity. Overall, rats exposed to TiO2 nanoparticles by a route that allows immediate systemic availability showed expected tissue distribution, no obvious toxic health effects, no immune response, and no change in organ function. Therefore, even with 100% bioavailability of the 5 mg/kg TiO2 dose afforded by the intravenous route of administration, there were no remarkable toxic effects evident in the experimental animals. These results indicate that TiO2 nanoparticles could be used safely in low doses.Keywords
This publication has 12 references indexed in Scilit:
- Inhalation Exposure Study of Titanium Dioxide Nanoparticles with a Primary Particle Size of 2 to 5 nmEnvironmental Health Perspectives, 2007
- Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administrationToxicology Letters, 2007
- Generation and Characterization of Test Atmospheres with NanomaterialsInhalation Toxicology, 2007
- Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategyParticle and Fibre Toxicology, 2005
- Mortality Among Workers Employed in the Titanium Dioxide Production Industry in EuropeCancer Causes & Control, 2004
- Pulmonary Responses of Mice, Rats, and Hamsters to Subchronic Inhalation of Ultrafine Titanium Dioxide ParticlesToxicological Sciences, 2004
- Universal reaction-limited colloid aggregationPhysical Review A, 1990
- Epidemiologic Study of Workers Exposed to Titanium DioxideJournal of Occupational and Environmental Medicine, 1988
- HIGH CONCENTRATION OF INJECTED TITANIUM DIOXIDE IN ABDOMINAL LYMPH NODESJournal of Experimental Medicine, 1966
- A quantitative study of the activity of the reticulo-endothelial structures in bone marrow in normal and ischemic limbs as indicated by India ink and titanium dioxideThe Anatomical Record, 1939